About Published works Copywriting, translation, speaking, and training Contact

Journalist with nearly a decade's experience writing and editing science news, opinion, features, and investigations. 

Words in Business Insider, BBC Science Focus, Live Science, The British Medical Journal, The Lancet, Nature Medicine, and others.

I turn around factchecked, tight, readable copy within the deadline without compromising on accuracy. I write for a range of audiences, from broadsheet news readers, to B2B, to high-level policymakers.

I have more than 700 bylines to my name, which have attracted tens of millions of pageviews. 

I write expertise in a variety of beats in science and health. At the moment, I am particularly fascinated by obesity and overweight and the interaction of fat with the metabolism. I also love writing about tech and science, and covering the business, politics, and economics of research. 

Featured Articles

Explore some of my latest and favorite work

British Medical Journal (BMJ) •

How do GLP-1 drugs work for weight loss . . . and everything else?

Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Wegovy/Ozempic) are constantly in the news for their staggering slimming effects. But it’s becoming clear that there is more to this drug class than weight loss.GLP-1 receptor agonists were once thought to be simple insulin regulators. Now, they’re known to act on the kidneys, heart, liver, brain, and more. “I think it’s absolutely fascinating and definitely very unusual that the potential indications are expanding so dramatical...
European Union, 2019
European Commissioner Olivér Várhelyi speaks at Brussels - EP, Brussels - European Parliament
The Lancet •

New EU Health Commissioner appointed amid controversy

Olivér Várhelyi's tempestuous confirmation process has seen pandemic preparedness and reproductive health stripped from his portfolio. Marianne Guenot reports.
Europe has a new Commissioner for Health and Animal Welfare. Olivér Várhelyi, the former European Commissioner for Neighbourhood and Enlargement, began his term on Dec 1, as part of European Commission President Ursula von der Leyen's second College of Commissioners.
The new role for Hungary's Várhelyi was among the most disputed, with Members of the European Parliament (MEPs) raising his connection to President Viktor Orbán and the controversial right-wing Fidesz party during his confirmation. Negotiations eventually led to sexual and reproductive health and pandemic preparedness being stripped from Várhelyi's portfolio.
Business Insider •

A Harvard professor is risking his reputation to search for aliens. Tech tycoons are bankrolling his quest.

Harvard's Avi Loeb has been setting the astrophysics world on fire with his claims that extraterrestrial tech could be behind recent near-Earth observations, his rising public persona, and his upcoming off-Broadway one-man show.

In this story, I spoke to the controversial professor to understand his motivation to search for signs of alien intelligence in Earth's backyard. I also investigated how he piqued the interest of wealthy counter-culture philanthropists to fund his quest.
Business Insider •

The moon is open for business, and entrepreneurs are racing to make billions

The moon could soon represent a market worth over $100 billion, piquing the interests of private companies like SpaceX, Blue Origin, Nokia, Lockheed Martin, and General Motors, to develop solutions for its lunar missions such as space-worthy rides, moon streaming, lunar GPS, and more.

This new market — worth over $100 billion— could be game-changing for humanity.

"Definitely the moon is going to be a big business," said Prachi Kawade, a senior analyst at NSR, a research-and-consulting company focused on the space market.
Nature Medicine •

Can quantum computing crack the biggest challenges in health? - Nature Medicine

Cleveland Clinic in the USA and the
UK National Health Service are both part of a burgeoning community of researchers, health systems and companies exploring applications of quantum computing in health. Although this nascent technology is at least a few years away from having practical applications — and some are warning of the
impending burst of the ‘quantum bubble’ —
many experts believe that biomedical and
healthcare research needs to be ready for the
quantum revolution of tomorrow.
“I know we are taking a gamble,” says
Lara Jehi, Cleveland Clinic’s chief research
information officer, who leads the institute’s
quantum research. Jehi hopes that “there is a
strategic, long-term advantage in being the
group that was first.”
Business Insider •

3 women share the terrifying experience of COVID-19 in pregnancy: 'This is not my time to go.'

When the doctor told Sultana Ashiq that she would have to be put "down to sleep" to go on a respirator as her lungs struggled against COVID-19, all Ashiq understood was "sleep."
Ashiq, a 33-year-old in London, was almost 31 weeks pregnant with twin girls, and she was exhausted. In the nine days since she had tested positive on January 11, her condition had rapidly declined — from shortness of breath and fever to gasping for air and unbearable pain.
Business Insider •

Climate change is already costing us money, but we have a chance to limit the worst of it and prosper. Here's how.

The ultimate goal, Amir Jina, an environmental economist at the University of Chicago, told Insider, should be to create a world where "climate or weather is a problem as boring as plumbing."
But to get there, we'll need to spend a lot of money up front and be real about the climate costs we're already paying — even if we don't always notice them.
Polytechnique Insights •

Drugs alone won't be enough to solve the obesity crisis

Drugs alone won’t be enough to solve the obesity crisis

Semaglu­tide, Ozem­pic, Wegovy… The names of these drugs have been seen across many head­lines recent­ly as they have shown promis­ing results for peo­ple with obe­si­ty, in and out of the lab. These drugs—designed to mim­ic gut hor­mone glucagon-like pep­tide 1 (GLP‑1)—have been tout­ed as near-mir­a­cles at a time when the obe­si­ty epi­dem­ic is rag­ing, with about 1 in 8 now liv­ing with the dis­ease. But can they real­ly solve a med­i
Business Insider •

OceanGate's cofounder wants to send 1,000 people to a floating colony on Venus by 2050, and says we shouldn't stop pushing the limits of innovation

The OceanGate expedition submersible tragedy raised questions about billionaire's ambitions to push the limits of the human experience for the sake of exploration. But Guillermo Söhnlein, OceanGate's co-founder, hasn't let the recent events dampen his ambition and claims humanity needs to continue pushing the limits of innovation.

He plans to send humans to live in the athmosphere of Venus. This aim, he says, is not as crazy as it seems. "I think it is less aspirational than putting a million people on the Martian surface by 2050," he told Business Insider.
Business Insider •

Killer whales hunt great white sharks all the time for their livers. 2 specific whales are famous for organizing kills.

Footage of orcas killing a great white shark by snapping at its liver entranced the internet recently.

But while the video — released ahead of a Discovery+ documentary — showed such a hunt in detail an expert told Insider that it wasn't unusual.

Indeed, in the waters off South Africa, the strategy is so common that two particular killer whales have gained a reputation for organizing teams of orcas to band together and hunt great whites.

This story is available exclusively to Business Insider
Business Insider •

Over 600 cubes of Nazi uranium made their way to the US after the war. 2 scientists are trying to figure out where they are now.

These paperweight-like cubes wouldn't raise an eyebrow on someone's desk.

"Marie Curie's granddaughter has one. She uses it as a doorstop," said an expert.

But these 2-inch uranium cubes were once important enough for the Allied forces to send a special task force, codenamed 'Alsos' to bring them back from Nazi Germany.

This story follows two science sleuths as they trace fourteen hand-sized uranium cubes back to Nazi Germany's first efforts to build a nuclear reactor, and the Manhattan Project's attempts to derail this plan.
Load More

Follow Me

Photo by Suzy Hazelwood on Pexels

Subscribe to get my new articles by email

Get an email (max one a week) when I publish articles on my portfolio. Unsubscribe anytime.